Advil (ibuprofen) Tablets, 200 mg, packaged as a) 360-count bottles (UPC 3 0573 0154 60 4), and b) 200-count bottles (UPC 3 0573 0154 21 5), Pfizer, Madison, NJ 07940
Published February 1, 2023 · Recall initiated: December 6, 2022
Summary
FDA records drug Class I recall D-0181-2023, published February 1, 2023 and initiated December 6, 2022. Recalling firm: Glaxosmithkline Consumer Healthcare Holdings DBA Haleon; Status: Terminated; Reported quantity: 321,246 tablets; Lot: a) Lots EJ2218, EJ2219, EJ2220, Exp 09/2023; b) Lot 953D, Exp 05/2025. Class I means a reasonable probability of serious adverse health consequences or death.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Labeling: Illegible Label; the adhesive migrated onto a portion of the label, causing it to tear when peeled back
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Glaxosmithkline Consumer Healthcare Holdings DBA Haleon
- Distributor
- Nationwide in the USA.
- Lot
- a) Lots EJ2218, EJ2219, EJ2220, Exp 09/2023; b) Lot 953D, Exp 05/2025
- Risk classification
- Class I
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAAdvil Liqui Gels (minis), Solubilized ibuprofen capsules, 200mg, Pain Reliever Fever Reducer (NSAID), 200February 1, 2023
- FDAAdvil Liqui Gels, Solubilized ibuprofen capsules, 200mg, Pain Reliever Fever Reducer (NSAID), 200 liquidFebruary 1, 2023
- FDAEpinephrine (L-Adrenaline), USP, CAS 51-43-4, Packaged in amber glass bottles in a vacuum sealed pouch asFebruary 1, 2023
- FDAEpinephrine (L-Adrenaline), USP, CAS 51-43-4, 1 KG amber glass bottle in a vacuum sealed pouch, Rx only,February 1, 2023
- FDASterile Water for Injection, USP, For Drug Diluent Use Only, 5 mL Single-Dose Vial, packaged in 30 x 5 mLFebruary 1, 2023
- FDAVancomycin Hydrochloride for Injection, USP, 1.5 g/vial, Sterile powder, Single-dose Fliptop Vial, 10 vialsFebruary 1, 2023
Questions about this recall
Was Advil (ibuprofen) Tablets, 200 mg, packaged as a) 360-count bottles (UPC 3 0573 0154 60 4), and b) 200-count bottles (UPC 3 0573 0154 21 5), Pfizer, Madison, NJ 07940 recalled?
Yes. FDA published recall D-0181-2023 on February 1, 2023. Reported hazard: Labeling: Illegible Label; the adhesive migrated onto a portion of the label, causing it to tear when peeled back
What should I do if I have this product?
Voluntary: Firm initiated · Letter